The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin
- 7 July 2005
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 32 (7) , 467-473
Abstract
Background: As the molecular mechanisms in melanoma chemoresistance remain unknown to date, we hypothesized these tumors to express the ATP‐binding cassette (ABC) transporter G2 (ABCG2/MXR/BCRP1/ABCP1), a recently detected membrane transporter and putative stem‐cell marker. Besides melanoma, we addressed the neuroendocrine carcinoma of the skin (Merkel cell carcinoma), another cutaneous cancer supposed to originate from neuroectoderm and usually chemoresistant.Methods and Results: Upon semiquantitative reverse transcription polymerase chain reaction, ABCG2 mRNA expression was not upregulated in 18 melanoma resection specimens when compared with 19 acquired melanocytic nevi from which melanomas are known to often arise (Mantel–Haenszel test, p = 0.3). At protein level, immunohistochemistry was negative in all 66 investigated melanoma resection specimens (50 primary melanomas and 16 cutaneous/subcutaneous metastases) and in 19 acquired melanocytic nevi. Among 29 neuroendocrine carcinomas of the skin, ABCG2 protein was detected in single clusters of cells in three tumors. As a positive control, three dermatofibrosarcomas were also stained and showed ABCG2 protein expression of the endothelial cells of the blood vessels.Conclusion: Altogether, chemoresistance of melanomas and neuroendocrine carcinomas of the skin cannot be explained by expression of the ABCG2‐chemoresistance gene. Most of these tumors do not exhibit this potential stem‐cell feature.Keywords
This publication has 32 references indexed in Scilit:
- High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study—TROG 96:07Journal of Clinical Oncology, 2003
- Side Population Keratinocytes Resembling Bone Marrow Side Population Stem Cells Are Distinct From Label-Retaining Keratinocyte Stem CellsJournal of Investigative Dermatology, 2003
- Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporterBiochemical and Biophysical Research Communications, 2002
- The Product of the ABC Half-Transporter Gene ABCG2 (BCRP/MXR/ABCP) Is Expressed in the Plasma MembraneBiochemical and Biophysical Research Communications, 2000
- Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon α2a and tamoxifen in metastatic melanomaMelanoma Research, 1999
- The incidence of malignant melanoma in the United States: Issues as we approach the 21st centuryJournal of the American Academy of Dermatology, 1996
- Glutathione and Related Enzymes in Tumor Progression and Metastases of Human MelanomaJournal of Investigative Dermatology, 1995
- Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cellsMelanoma Research, 1992
- Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry.Journal of Histochemistry & Cytochemistry, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981